BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8029521)

  • 21. Bronchiolitis obliterans in recipients of single, double, and heart-lung transplantation.
    Keller CA; Cagle PT; Brown RW; Noon G; Frost AE
    Chest; 1995 Apr; 107(4):973-80. PubMed ID: 7705164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation.
    Ailawadi G; Smith PW; Oka T; Wang H; Kozower BD; Daniel TM; Kron IL; Jones DR
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):594-602. PubMed ID: 18329476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome.
    Smith MA; Sundaresan S; Mohanakumar T; Trulock EP; Lynch JP; Phelan DL; Cooper JD; Patterson GA
    J Thorac Cardiovasc Surg; 1998 Nov; 116(5):812-20. PubMed ID: 9806388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome.
    Daud SA; Yusen RD; Meyers BF; Chakinala MM; Walter MJ; Aloush AA; Patterson GA; Trulock EP; Hachem RR
    Am J Respir Crit Care Med; 2007 Mar; 175(5):507-13. PubMed ID: 17158279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of obliterative bronchiolitis after heart-lung transplantation in children.
    Whitehead B; Rees P; Sorensen K; Bull C; Higenbottam TW; Wallwork J; Fabre J; Elliott M; de Leval M
    J Heart Lung Transplant; 1993; 12(6 Pt 1):903-8. PubMed ID: 8312313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunologically mediated disease of the airways after pulmonary transplantation.
    Griffith BP; Paradis IL; Zeevi A; Rabinowich H; Yousem SA; Duquesnoy RJ; Dauber JH; Hardesty RL
    Ann Surg; 1988 Sep; 208(3):371-8. PubMed ID: 3048217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune factors correlating with improved long-term graft outcome in kidney, lung, and heart transplants.
    Reinsmoen NL; Hertz MI; Kubo S; Bolman RM; Matas AJ
    Transplant Proc; 1993 Dec; 25(6):3277-8. PubMed ID: 8266541
    [No Abstract]   [Full Text] [Related]  

  • 28. Obliterative bronchiolitis after lung and heart-lung transplantation.
    Reichenspurner H; Girgis RE; Robbins RC; Conte JV; Nair RV; Valentine V; Berry GJ; Morris RE; Theodore J; Reitz BA
    Ann Thorac Surg; 1995 Dec; 60(6):1845-53. PubMed ID: 8787504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The number of FoxP3+ cells in transbronchial lung allograft biopsies does not predict bronchiolitis obliterans syndrome within the first five years after transplantation.
    Krustrup D; Iversen M; Martinussen T; Schultz HH; Andersen CB
    Clin Transplant; 2015 Mar; 29(3):179-84. PubMed ID: 25533723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bronchiolitis obliterans and airways obstruction associated with graft-versus-host disease.
    Epler GR
    Clin Chest Med; 1988 Dec; 9(4):551-6. PubMed ID: 3069287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aggressive coronary artery vasculopathy after combined heart-lung transplantation.
    Hayes D; Baker PB; Astor TL; Preston TJ; Kirkby S; Galantowicz M; Hoffman TM
    Congenit Heart Dis; 2013; 8(3):E88-91. PubMed ID: 22676698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bronchiolitis obliterans: the Achilles heel of lung transplantation.
    Frost AE
    Verh K Acad Geneeskd Belg; 2002; 64(5):303-19; discussion 319-22. PubMed ID: 12647579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First experience with FK 506 for treatment of chronic pulmonary rejection.
    Reichenspurner H; Meiser BM; Kur F; Wagner F; Welz A; Uberfuhr P; Briegel H; Reichart B
    Transplant Proc; 1995 Jun; 27(3):2009. PubMed ID: 7540775
    [No Abstract]   [Full Text] [Related]  

  • 34. [Anatomoclinical diversity of bronchiolitis obliterans after lung transplantation. Anatomical study of 16 cases among 64 transplantations].
    Loire R; Brune J; Cordier JF; Mornex JF; Philit F; Roux N; Tabib A
    Arch Anat Cytol Pathol; 1993; 41(5-6):232-9. PubMed ID: 8135585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Post-lung transplantation bronchiolitis obliterans].
    Fournier M; Groussard O; Mal H; Sleiman C; Duchatelle JP; Andreassian B; Pariente R
    Rev Mal Respir; 1995; 12(1):5-11. PubMed ID: 7899668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Bronchiolitis obliterans after lung transplantation].
    Fournier M; Groussard O; Sleiman C; Mal H; Darne C; Pariente R
    Presse Med; 1992 May 2-9; 21(17):816-20. PubMed ID: 1535143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation.
    Reichenspurner H; Girgis RE; Robbins RC; Yun KL; Nitschke M; Berry GJ; Morris RE; Theodore J; Reitz BA
    Ann Thorac Surg; 1996 Nov; 62(5):1467-72; discussion 1472-3. PubMed ID: 8893585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation.
    Jaramillo A; Fernández FG; Kuo EY; Trulock EP; Patterson GA; Mohanakumar T
    Pediatr Transplant; 2005 Feb; 9(1):84-93. PubMed ID: 15667618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does histologic acute rejection in lung allografts predict the development of bronchiolitis obliterans?
    Yousem SA; Dauber JA; Keenan R; Paradis IL; Zeevi A; Griffith BP
    Transplantation; 1991 Aug; 52(2):306-9. PubMed ID: 1871804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The immunohistopathology of obliterative bronchiolitis following lung transplantation.
    Milne DS; Gascoigne A; Wilkes J; Sviland L; Ashcroft T; Pearson AD; Malcolm AJ; Corris P
    Transplantation; 1992 Oct; 54(4):748-50. PubMed ID: 1412772
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.